The Sundance Channel has acquired all North American rights to Mark Decana’s romantic drama “Dopamine” as the second title to go out through the Sundance Film Series. Pic launches theatrically in the fall before segueing to exposure through Sundance’s home entertainment division and cable web.
The deal follows Sundance’s pickup earlier this month of Michael Winterbottom’s Berlin fest Golden Bear winner “In This World,” which will be the first of four titles to be packaged in the series.
Sundance has pacted with Loews Theaters in 10 key theatrical markets — New York, Los Angeles, Baltimore, Boston, Chicago, Dallas, Detroit, San Francisco, Seattle and Washington D.C. — for a guaranteed two-week run on separate dates starting in September. Sundance Channel will oversee launch and management of the series.
The “Dopamine” acquisition was negotiated by law firm Lichter, Grossman, Nichols, Adler & Goodman, and by producer’s rep Jeff Dowd on behalf of the filmmaker, and for Sundance Channel Entertainment by Christian Vesper, VP, acquisitions.
An examination of the relationship between love, chemistry and artificial intelligence as experienced by a trio of partners in a tech startup company, “Dopamine” also will screen as the closing-night event of the San Francisco Intl. Film Festival on May 1. John Livingston, Bruno Campus, Rueben Grundy and Sabrina Lloyd star in the film, which was produced by Tad Fettig and Debbie Brubaker, with Eric Koivisto exec producing.
The pickup makes Decana’s film the first to be fostered through every phase of the Sundance network, from the Sundance Institute Labs, where the script was developed, to the fest, where it premiered in January. Following the theatrical dates, Sundance Channel Home Entertainment will release the film on video and DVD, with broadcast on the Sundance Channel completing the chain.